ASTS
AST SpaceMobile, Inc.
ASTS offers stronger fundamentals, but that advantage does not outweigh its weaker overall profile.
CHKP
Check Point Software Technologies Ltd.
CHKP has the edge over ASTS overall, supported by lower modeled downside and stronger valuation.
ASTS Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Weak | |
| Weak | |
| Unavailable |
ASTS's revenue is currently healthy, but its profitability and cash flow are weak. There isn't enough data to rate its balance sheet.
CHKP Fundamentals
| Metric | Status |
|---|---|
| Stable | |
| Strong | |
| Strong | |
| Stable |
CHKP's profitability and cash flow are currently strong, and its revenue and balance sheet are stable.
ASTS PE Valuation
ASTS has no meaningful PE right now: it lost money over the past year.
CHKP PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Forward | 14x | $147 | — |
| Current | 15x | $147 | — |
| Cheap | 19x | $187 | +26% |
| Fair | 21x | $203 | +38% |
| Expensive | 25x | $241 | +64% |
Historical ranges are pointers, not guarantees.
CHKP's PE is in its cheap range at 15x. If earnings grow as analysts expect, today's price would be 14x next year's earnings.
ASTS Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Losses growing | |
| Strong growth | |
| -- | |
| Limited | |
| Low |
Analysts expect ASTS's losses to grow, with revenue growing. However, they disagree widely on these estimates.
CHKP Forward outlook
| Metric | Outlook |
|---|---|
| Improving | |
| Growth | |
| Stable | |
| Improving | |
| Moderate | |
| Moderate |
Analysts expect CHKP's earnings to grow and its profitability to improve, with its revenue holding steady.
ASTS Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Q3 2026 | -$2.15 | -$0.91 |
| Q2 2026 | -$2.16 | -$0.27 |
| Q1 2026 | -$1.80 | +$0.19 |
| Q4 2025 | -$1.34 | +$0.61 |
| Q3 2025 | -$1.24 | +$0.88 |
| Q2 2025 | -$1.89 | -$0.64 |
| Q1 2025 | -$1.99 | -$1.01 |
| Q4 2022 | -$0.58 | -$0.21 |
ASTS is still losing money, but far less than before: $2.15 per share over the past year, against $5.76 at its worst in mid-2021.
CHKP Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $10.74 | +10% |
| Q2 2026 | $9.73 | +27% |
| Q1 2026 | $9.70 | +28% |
| Q4 2025 | $9.60 | +29% |
| Q3 2025 | $9.13 | +25% |
| Q2 2025 | $7.68 | +6.1% |
| Q1 2025 | $7.58 | +5.4% |
| Q4 2024 | $7.47 | +5.1% |
| Q3 2024 | $7.32 | +2.2% |
CHKP has the edge over ASTS on earnings quality, reporting a profit while its opponent remains loss making.
ASTS Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $42.3M | +187% |
| Q2 2026 | $31.5M | +2627% |
| Q1 2026 | $14.7M | +1952% |
| Q4 2025 | $54.3M | +2731% |
| Q3 2025 | $14.7M | +1240% |
| Q2 2025 | $1.2M | +28% |
| Q1 2025 | $718K | +44% |
| Q3 2022 | $4.2M | +70% |
ASTS's revenue has grown year over year for 11 quarters in a row: $42M last quarter, up 187% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | -415% | +694 points |
| Q2 2026 | -948% | +10744 points |
| Q1 2026 | -1686% | +7083 points |
| Q4 2025 | -175% | +2446 points |
| Q3 2025 | -1109% | +4850 points |
| Q2 2025 | -11692% | -4693 points |
| Q1 2025 | -8769% | +2331 points |
| Q4 2024 | -2621% | N/A |
ASTS's operating margin was −415% last quarter, up 694 points from the same quarter a year ago.
CHKP Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q2 2026 | $673.6M | +1.3% |
| Q1 2026 | $668.4M | +4.8% |
| Q4 2025 | $744.9M | +5.9% |
| Q3 2025 | $677.5M | +6.7% |
| Q2 2025 | $665.2M | +6% |
| Q1 2025 | $637.8M | +6.5% |
| Q4 2024 | $703.7M | +6.1% |
| Q3 2024 | $635.1M | +6.5% |
CHKP's revenue has grown year over year every quarter since late 2020: $674M last quarter, up 1.3% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q2 2026 | 27% | -3.1 points |
| Q1 2026 | 28% | -3 points |
| Q4 2025 | 31% | -4.9 points |
| Q3 2025 | 29% | -5 points |
| Q2 2025 | 31% | -2.8 points |
| Q1 2025 | 31% | -1.7 points |
| Q4 2024 | 36% | -1.8 points |
| Q3 2024 | 34% | -3.5 points |
CHKP has the edge over ASTS on profitability, with a higher operating margin.
ASTS Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$464.2M | -$161.4M |
| Q2 2026 | -$694.8M | -$341.1M |
| Q1 2026 | -$309.7M | -$160.7M |
| Q4 2025 | -$330.7M | -$220.3M |
| Q3 2025 | -$302.9M | -$239.1M |
| Q2 2025 | -$353.6M | -$315.3M |
| Q1 2025 | -$149M | -$61.3M |
| Q4 2024 | -$110.5M | -$63.2M |
ASTS has burned cash in almost every quarter: −$1.8B over the past year, against −$916M the year before.
CHKP Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q2 2026 | $160.7M | -37% |
| Q1 2026 | $435.9M | +5.4% |
| Q4 2025 | $277.3M | +17% |
| Q3 2025 | $265.1M | +8.6% |
| Q2 2025 | $256M | +32% |
| Q1 2025 | $413.7M | +17% |
| Q4 2024 | $236.1M | +0.8% |
| Q3 2024 | $244.1M | +13% |
CHKP has the edge over ASTS on cash generation, producing positive trailing cash flow while its opponent burns cash.
ASTS Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.4% | +1.1M shares |
| 1 year | +10% | +27.3M shares |
| 3 years | +235% | +211M shares |
| 5 years | +480% | +248M shares |
| Available history | +944% | +271M shares |
ASTS has 300M diluted shares, up 10% from a year ago.
| Quarter | Spent |
|---|---|
| Q1 2025 | — |
| Q4 2024 | — |
| Q3 2024 | — |
| Q2 2024 | — |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
CHKP Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | -2.5% | -2.6M shares |
| 1 year | -6.3% | -6.9M shares |
| 3 years | -13% | -15.7M shares |
| 5 years | -23% | -31.3M shares |
| Available history | -31% | -47.3M shares |
CHKP has the edge over ASTS on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q2 2026 | $324.9M |
| Q1 2026 | $325M |
| Q4 2025 | $425M |
| Q3 2025 | $366.8M |
| Q2 2025 | $325M |
| Q1 2025 | $325M |
| Q4 2024 | $324.9M |
| Q3 2024 | $325M |
CHKP spent $1.4B buying back its own shares over the past year, up 11% from the year before.
ASTS Net Leverage
ASTS's operating earnings (EBITDA) were negative over the past year, so its debt can't be measured against them.
CHKP Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q2 2026 | 1.5x | Healthy |
| Q1 2026 | 0.9x | Very low |
| Q4 2025 | 0.2x | Very low |
| Q3 2025 | -0.6x | Net Cash |
| Q2 2025 | -0.6x | Net Cash |
| Q1 2025 | -0.4x | Net Cash |
| Q4 2024 | -0.5x | Net Cash |
| Q3 2024 | -0.5x | Net Cash |
CHKP's net debt is about 1.5 years of its operating earnings (EBITDA), after holding more cash than debt a year ago.
ASTS Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 34.1 | Neutral |
| Stochastic | 11.9 | Oversold |
ASTS's weekly RSI is 34 (neutral) and its Stochastic is 12 (oversold).
CHKP Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.5 | Neutral |
| Stochastic | 62.8 | Neutral |
CHKP's weekly RSI is 55 (neutral) and its Stochastic is 63 (neutral).
ASTS PE vs Technology Sector
ASTS has no meaningful PE right now: it lost money over the past year.
CHKP PE vs Technology Sector
| Metric | CHKP | Sector median | Relative |
|---|---|---|---|
| PE | 15x | 28x | 46% below |
| PE % | 8 | 35 | 27 pts below |
CHKP is trading at 15x earnings, a 46% discount to the Technology sector's median of 28x.
ASTS Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $44.9 | 23% below |
| 20 week MA | $57.1 | 40% below |
| 50 week MA | $75.5 | 54% below |
| 100 week MA | $57.8 | 40% below |
| 200 week MA | $33.6 | 2.8% above |
ASTS has fallen below most of its moving averages, though it's still 2.8% above its 200-week average.
CHKP Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $142.4 | 3.6% above |
| 20 week MA | $136.6 | 8% above |
| 50 week MA | $147.6 | 0.1% below |
| 100 week MA | $177.1 | 17% below |
| 200 week MA | $164.5 | 10% below |
CHKP has the edge over ASTS on trend strength, trading above more of its moving averages.
ASTS Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $9.87 | $13.4 | +36% |
| 2021 | $13.4 | $8.71 | -35% |
| 2022 | $8.71 | $3.97 | -54% |
| 2023 | $3.97 | $6.03 | +52% |
| 2024 | $6.03 | $22.9 | +280% |
| 2025 | $22.9 | $72.0 | +214% |
| 2026 YTD | $72.0 | $34.5 | -52% |
ASTS's yearly returns have swung widely, from +280% in 2024 to −54% in 2022. It's down 52% so far in 2026.
CHKP Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $111.8 | $134.8 | +21% |
| 2021 | $134.8 | $114.9 | -15% |
| 2022 | $114.9 | $127.0 | +11% |
| 2023 | $127.0 | $152.8 | +20% |
| 2024 | $152.8 | $187.9 | +23% |
| 2025 | $187.9 | $189.6 | +0.9% |
| 2026 YTD | $189.6 | $147.5 | -22% |
CHKP has the edge over ASTS on returns for 2026, with the stronger performance.